Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-000447-27Phase 2Suspended
Phase 2, open-label, single-arm trial of midazolam, torasemide, codeine and pravastatin, sponsored by Universitätsklinikum Schleswig-Holstein. Primary endpoint: Blood levels and clearance of probe drugs. Started Apr 2012; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-000447-27.